Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Evotec Dividend Announcement
• Evotec announced a monthly dividend of $0.29 per ordinary share which will be made payable on . Ex dividend date: 2019-01-11
• Evotec's trailing twelve-month (TTM) dividend yield is -%
Evotec Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2019-01-11 | $0.29 | monthly | |
2018-12-12 | $0.18 | monthly | |
2018-11-08 | $0.18 | monthly | |
2018-10-10 | $0.18 | monthly | |
2018-09-13 | $0.18 | monthly | |
2018-08-10 | $0.18 | monthly | |
2018-07-11 | $0.18 | monthly | |
2018-06-08 | $0.18 | monthly | |
2018-05-10 | $0.18 | monthly | |
2018-04-11 | $0.18 | monthly | |
2018-03-09 | $0.18 | monthly | |
2018-02-09 | $0.18 | monthly | |
2018-01-11 | $0.18 | monthly | |
2017-12-08 | $0.18 | monthly | |
2017-11-10 | $0.18 | monthly | |
2017-10-11 | $0.18 | monthly | |
2017-09-08 | $0.18 | monthly | |
2017-08-09 | $0.18 | monthly | |
2017-07-11 | $0.18 | monthly | |
2017-06-08 | $0.20 | monthly | |
2017-05-09 | $0.20 | monthly | |
2017-04-11 | $0.20 | monthly | |
2017-03-09 | $0.20 | monthly | |
2017-02-09 | $0.20 | monthly | |
2017-01-11 | $0.20 | monthly | |
2016-12-08 | $0.20 | monthly | |
2016-11-09 | $0.20 | monthly | |
2016-09-08 | $0.20 | monthly | |
2016-08-09 | $0.20 | monthly | |
2016-06-09 | $0.24 | monthly | |
2016-05-10 | $0.24 | monthly | |
2016-04-07 | $0.24 | monthly | |
2016-03-09 | $0.24 | monthly | |
2016-02-09 | $0.24 | monthly | |
2016-01-12 | $0.24 | monthly | |
2015-12-09 | $0.24 | monthly | |
2015-11-10 | $0.24 | monthly | |
2015-10-08 | $0.24 | monthly | |
2015-09-09 | $0.24 | monthly | |
2015-08-11 | $0.24 | monthly | |
2015-07-09 | $0.24 | monthly | |
2015-06-09 | $0.24 | monthly |
Evotec Dividend per year
Evotec Dividend growth
Evotec Dividend Yield
Evotec current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Evotec stock? Use our calculator to estimate your expected dividend yield:
Evotec Financial Ratios
Evotec Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy Evotec stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.